Expertise in
4
conditions

Maarten W. Van Den Berge

Groningen, GR, NL 
Expertise in
4
conditions
Groningen, GR, NL 

Overview

Maarten Van Den Berge practices practicing medicine in Groningen, Netherlands.

Van Den Berge is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Emphysema, Stent Placement, and Endoscopy.

They are actively involved in clinical research, co-authoring 349 peer reviewed articles and participating in 2 clinical trials.

Locations

Groningen, GR, Netherlands
Other Locations
Eindhoven, NB 5602ZA, Netherlands
Nijmegen, GE, Netherlands
The Hague, Netherlands
Haag, LI, Netherlands
Leiden, ZH 2333ZA, Netherlands
Utrecht, UT, Netherlands
Amsterdam, NH, Netherlands
Arnhem, GE, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomaticphospholamban R14del Carriers)
PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomaticphospholamban R14del Carriers)
Enrollment Status: Completed
Publish Date: October 18, 2021
Intervention Type: Drug
Study Drug: Eplerenone
Study Phase: Phase 3
Effectiveness of Single Inhaler Maintenance and Reliever Therapy With Spiromax® Budesonide/Formoterol (SMART) Versus Fixed Dose Treatment With Diskus® Fluticasone/Salmeterol in Patients With a Chronic Obstructive Pulmonary Disease (COPD)
Effectiveness of Single Inhaler Maintenance and Reliever Therapy With Spiromax® Budesonide/Formoterol (SMART) Versus Fixed Dose Treatment With Diskus® Fluticasone/Salmeterol in Patients With a Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Unknown
Publish Date: July 10, 2019
Intervention Type: Drug
Study Drugs: Spiromax Budesonide/Formoterol, Diskus Fluticasone/Salmeterol
Study Phase: Phase 3
View 1 Less Clinical Trial

348 Total Publications

Tozorakimab to Prevent COPD Exacerbations.
Tozorakimab to Prevent COPD Exacerbations.
Journal: The New England journal of medicine
Published: September 08, 2026

Frequently Asked Questions about Maarten W. Van Den Berge

Is Maarten W. Van Den Berge a top-rated expert for Chronic Obstructive Pulmonary Disease (COPD)?

MediFind is an objective health platform that identifies experts based on real-world data. Maarten W. Van Den Berge is classified as an Distinguished expert for Chronic Obstructive Pulmonary Disease (COPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maarten W. Van Den Berge participate in research or clinical trials?

Yes. Maarten W. Van Den Berge has published 348 articles and abstracts on conditions like Chronic Obstructive Pulmonary Disease (COPD). You can view a list of Maarten W. Van Den Berge's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Van Den Berge's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile